A Phase 1 First in Human Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PLX 5622 in Healthy Adult Volunteers.
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2015
At a glance
- Drugs PLX 5622 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 26 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2011 New trial record